Stay updated on Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial
Sign up to get notified when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.

Latest updates to the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and may not be about the study; updated revision to v3.3.2. Removed the previous wording stating that publications come from PubMed and are automatically created by ClinicalTrials.gov Identifier (NCT Number) and the older revision reference v3.2.0.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding lapse notice from the top of the page.SummaryDifference0.4%

- Check34 days agoChange DetectedResults First Posted date (2024-12-27) and updated Study Record Dates were added, and a PubMed publication (Nat Med 2023) is linked. The page now includes the study's enrollment (36) and access to the protocol and consent forms.SummaryDifference0.4%

- Check63 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check70 days agoChange DetectedPage updates version from v3.0.2 to v3.1.0 and removes a specific disease resource; otherwise, core content remains unchanged.SummaryDifference0.4%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.